Vitalograph Inc products

Electronic clinical outcome assessments (eCOA) are integrated into Vitalograph’s validated clinical trials solutions allowing multiple endpoints to be collected in clinic or at home, and centralized. eCOA are collected by Vitalograph on the COMPACT™  Medical Workstation (in-clinic) and the In2itive™ e-Diary (home setting). eCOA, along with all other assessments, are managed and centralized through Spirotrac® software. We offer eCOA when we are also collecting respiratory endpoints using the COMPACT or In2itive e-Diary. Vitalograph has a number of pre-validated PROs available and we liaise with eCOA license and copyright holders as required. Centralizing the eCOA data with the other respiratory endpoints creates an efficiency in respiratory trials.  It reduces costs and specification time as well as the need for managing and collating multiple datasets.  

Ideal for monitoring PEF and FEV1 at home, work, in clinical trials, in primary or secondary care. The Vitalograph asma-1™ is a lightweight home use electronic respiratory monitor that measures PEF and FEV1. It offers greater accuracy than mechanical peak flow meters and eliminates the need for paper record cards. Links easily to other devices by USB for reporting. Measures FEV1 and PEF. Displays % of personal best FEV1. Electronic record – no need for record cards. Set unique ‘personal best’ zones for test subjects. Automatically stores best values in a test session. Quality of blow indicator. 600 test memory. Suitable for use with Bacterial Viral Filters (BVF™). Compliant with: ATS/ERS 2019 and ISO 23747 / 26782 / 13485. Large, easy to read display.

Fast & accurate COPD screener to identify those at risk of COPD at the pre-symptomatic stage. The Vitalograph copd-6™ identifies those at risk of COPD at the pre-symptomatic stage. The device screens out those whose FEV1 is normal. The copd-6 screener allows early medical intervention and facilitates better clinical outcomes. Monitors COPD patients using their ‘number’, the obstructive index which is based on a percent of predicted. Facilitates ‘case selection’ so that spirometry can be focused on those likely to be diagnosed with COPD. Screens out anyone with normal FEV1 without the risk of false COPD negatives. Displays FEV1, FEV6, ratio and % predicted, obstructive index, COPD classification and lung age. Displays the GOLD COPD classification (stage I – IV) to help recognize the need for a change in the patient’s management plan. Built-in quality of blow indicator. Large, easy-to-read display.